
LINDERA offers AI-powered mobility analysis solutions primarily for the healthcare and elderly care sectors. Their products focus on fall prevention and gait analysis, utilizing 3D movement analysis via smartphone apps. Key products include L.Care for professional fall risk assessment in care facilities, L.Home for home-based risk reduction, L.Gait for app-based gait analysis for medical technology and research, and L.Ortho for digital therapy and rehabilitation. LINDERA aims to simplify risk assessment, provide actionable recommendations, and measure progress, integrating with existing healthcare documentation systems. The company highlights scientific validation, noting that their mobility analysis can reduce fall risk by up to 18%. They emphasize supporting healthcare professionals by reducing the time spent on risk assessment and documentation.

LINDERA offers AI-powered mobility analysis solutions primarily for the healthcare and elderly care sectors. Their products focus on fall prevention and gait analysis, utilizing 3D movement analysis via smartphone apps. Key products include L.Care for professional fall risk assessment in care facilities, L.Home for home-based risk reduction, L.Gait for app-based gait analysis for medical technology and research, and L.Ortho for digital therapy and rehabilitation. LINDERA aims to simplify risk assessment, provide actionable recommendations, and measure progress, integrating with existing healthcare documentation systems. The company highlights scientific validation, noting that their mobility analysis can reduce fall risk by up to 18%. They emphasize supporting healthcare professionals by reducing the time spent on risk assessment and documentation.
Headquarters: Berlin, Germany
Core product: AI-powered smartphone apps for markerless 3D gait and mobility analysis
Primary markets: Healthcare: fall prevention, care facilities, home care, orthopaedics & rehab
Regulatory status: CE-marked medical device (Class I)
Notable funding: Series A ~€6M (Sep/Nov 2021)
Fall prevention, gait/mobility assessment and rehabilitation in healthcare and elderly care.
2017
Digital health / MedTech
€6,000,000
Announced September 2021; reported participation from entrepreneur investors and investor group.
“zwei.7 led a Series A alongside entrepreneur investors”